BRIEF published on 04/07/2026 at 07:05, 5 months 26 days ago BioVersys annonce la tenue de son assemblée générale annuelle des actionnaires en 2026. Élections Du Conseil D'administration Innovation Pharmaceutique Inscription Des Actionnaires Assemblée Générale Annuelle De BioVersys 2026 États Financiers 2025
BRIEF published on 04/07/2026 at 07:05, 5 months 26 days ago BioVersys Announces 2026 Annual General Meeting of Shareholders Board Elections Pharmaceutical Innovation Shareholder Registration BioVersys AGM 2026 Financial Statements 2025
PRESS RELEASE published on 04/07/2026 at 07:00, 5 months 26 days ago BioVersys Issues Invitation to its 2026 Annual General Meeting of Shareholders BioVersys issues invitation to its 2026 AGM, including key agenda items and election updates. Shareholders' participation details provided Shareholders AGM Meeting 2026 BioVersys
BRIEF published on 04/02/2026 at 07:05, 6 months 1 day ago BioVersys Names Anca Cighi as Head of Investor Relations Investor Relations Biopharmaceutical BioVersys Anca Cighi Drug-resistant
BRIEF published on 04/02/2026 at 07:05, 6 months 1 day ago BioVersys nomme Anca Cighi à la tête des relations avec les investisseurs Biopharmaceutique Relations Avec Les Investisseurs BioVersys Anca Cighi Résistant Aux Médicaments
PRESS RELEASE published on 04/02/2026 at 07:00, 6 months 1 day ago BioVersys Appoints Anca Cighi as Head of Investor Relations and Communications BioVersys AG appoints Anca Cighi as Head of Investor Relations and Communications. Anca brings 15 years of experience to the role Investor Relations Communications BioVersys AG Antibacterial Products Anca Cighi
BRIEF published on 03/31/2026 at 07:05, 6 months 3 days ago BioVersys and Hackensack Meridian Health Collaborate on NTM Research Collaboration BioVersys Ansamycin NTM Research Hackensack Meridian
BRIEF published on 03/31/2026 at 07:05, 6 months 3 days ago BioVersys et Hackensack Meridian Health collaborent à la recherche sur les mycobactéries non tuberculeuses (MNT). Collaboration BioVersys Ansamycin Recherche Sur Les Mycobactéries Non Tuberculeuses Méridien De Hackensack
PRESS RELEASE published on 03/31/2026 at 07:00, 6 months 3 days ago BioVersys strengthens Ansamycin platform and NTM research through collaboration and license agreement with Hackensack Meridian Health BioVersys strengthens Ansamycin platform and NTM research through collaboration and license agreement with Hackensack Meridian Health Collaboration BioVersys NTM Ansamycin Hackensack Meridian Health
BRIEF published on 03/18/2026 at 07:05, 6 months 16 days ago BioVersys dévoile ses réalisations et ses performances financières pour 2025 Résultats Financiers Essais Cliniques BioVersys Médicaments Antibactériens Financement Des Introductions En Bourse
Published on 10/03/2026 at 02:35, 14 hours 40 minutes ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 1 day 3 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 4 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 4 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/03/2026 at 15:45, 1 hour 30 minutes ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 17 hours 20 minutes ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 20 hours 51 minutes ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 21 hours 29 minutes ago innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 19:00, 22 hours 15 minutes ago INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 10/02/2026 at 17:45, 23 hours 30 minutes ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 23 hours 30 minutes ago Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 23 hours 40 minutes ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 23 hours 45 minutes ago Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/02/2026 at 17:30, 23 hours 45 minutes ago Aéroports de Paris SA - Calendrier financier 2027
